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Abstract
HIV-1 Nef enhances dendritic cell (DC)-mediated viral transmission to CD4
+ T cells, but the underlying mechanism is not fully
understood. It is also unknown whether HIV-1 infected DCs play a role in activating CD4
+ T cells and enhancing DC-
mediated viral transmission. Here we investigated the role of HIV-1 Nef in DC-mediated viral transmission and HIV-1
infection of primary CD4
+ T cells using wild-type HIV-1 and Nef-mutated viruses. We show that HIV-1 Nef facilitated DC-
mediated viral transmission to activated CD4
+ T cells. HIV-1 expressing wild-type Nef enhanced the activation and
proliferation of primary resting CD4
+ T cells. However, when co-cultured with HIV-1-infected autologous DCs, there was no
significant trend for infection- or Nef-dependent proliferation of resting CD4
+ T cells. Our results suggest an important role
of Nef in DC-mediated transmission of HIV-1 to activated CD4
+ T cells and in the activation and proliferation of resting CD4
+
T cells, which likely contribute to viral pathogenesis.
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Introduction
Dendritic cells (DCs) are among the first cells that encounter
HIV-1 at the mucosa, and play a critical role in HIV-1 infection
[1,2,3,4]. Immature DCs allow productive HIV-1 replication and
long-term viral dissemination [5,6,7,8,9]. DC-SIGN (DC-specific
intercellular adhesion molecule 3 grabbing non-integrin) is a C-
type lectin that enhances HIV-1 trans-infection [10]. DC-SIGN-
expressing immature DCs from human rectal mucosa efficiently
bind and transfer HIV-1 to CD4
+ T cells [11]. Although DC-
SIGN
+ cells comprise only 1–5% of total mucosal mononuclear
cells, they account for greater than 90% of HIV-1 binding, since
DC-SIGN antibodies block 90% of this binding [11]. Previous
studies have suggested that DC-SIGN partially contributes to
immature DC-mediated HIV-1 transmission and that DC
maturation enhances HIV-1 transmission efficiency
[12,13,14,15,16,17,18,19,20,21,22]. However, the precise me-
chanisms underlying DC-mediated HIV-1 transmission to CD4
+
T cell remain to be defined.
The Nef protein of HIV-1 and simian immunodeficiency virus
(SIV) is a pathogenic factor in vivo [23,24,25,26], and contributes
to many aspects of primate lentiviral immunopathogenesis through
its interactions with host proteins [27,28,29,30,31]. HIV-1 Nef is
required for efficient viral replication in co-cultures of DCs and
activated CD4
+ T cells or peripheral blood mononuclear cells
(PBMCs) [9,32,33]. HIV-1 Nef up-regulates DC-SIGN expression
of infected DCs, increases clustering of DCs with CD4
+ T cells,
and modulates DC and CD4
+ T cell activation [9,34,35,36].
Immunoactivation facilitates HIV-1 replication and leads to CD4
+
T cell depletion and AIDS pathogenesis [37], but it is unclear
whether Nef expression in HIV-1 infected DCs plays a role in
activating CD4
+ T cells and enhancing cell-to-cell transmission.
Previous studies have indicated inconsistent functions of HIV-1
Nef in CD4
+ T cell activation [29], which need to be clarified
using wild-type (WT) HIV-1 and Nef-mutated viruses of primary
resting CD4
+ T cells. Moreover, HIV-1 Nef down-regulates
surface CD4 expression on infected DCs and CD4
+ T cells [9,38].
We have reported that CD4 co-expression with DC-SIGN blocks
DC-SIGN-mediated transmission of HIV-1 [9]. However, it
remains unclear whether the effects of Nef on the expression of
CD4 and DC-SIGN affect DC-mediated HIV-1 transmission to
CD4
+ T cells.
In this study, we investigated the role of HIV-1 Nef in DC-
mediated viral transmission and HIV-1 infection of primary CD4
+
T cells using WT HIV-1 and HIV-1 expressing mutated Nef
proteins. We show that Nef promotes DC-mediated HIV-1
transmission to activated CD4
+ T cells, and that Nef expression
promotes activation and proliferation of resting CD4
+ T cells to
enhance HIV-1 infection of these cells. Our results suggest an
important role of Nef in DC-mediated transmission of HIV-1 to
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+ T cells and in the activation and proliferation of
resting CD4
+ T cells, which likely contribute to viral pathogenesis.
Results
HIV-1 Nef enhances DC-mediated HIV-1 transmission to
CD4
+ T cells and modulates CD4 expression of DCs
To examine whether Nef expression in DCs can modulate DC-
mediated HIV-1 transmission to CD4
+ T cells, immature mono-
cyte-derived DCs (MDDCs) were transduced with a vesicular
stomatitis virus G protein (VSV-G)-pseudotyped, Nef-expressing
lentiviral vector and then tested for the ability to transmit single-
cycle HIV-1 to CD4
+ Hut/CCR5 T cells. A VSV-G-pseudotyped
Nef-deleted lentiviral vector was used as a negative control. These
HIV-1-derived lentiviral vectors are defective for vif, vpr, vpu, and
env genes [39]. Nef expression in the transduced MDDCs was
confirmed by immunoblotting (Fig. 1A). The vector-transduced
cells were pulsed with R5-tropic, Nef-defective, single-cycle
luciferase HIV-1 [12], and co-cultured with CD4
+ Hut/CCR5
T cells. Nef expression in DCs enhanced HIV-1 transmission by 6-
to 8-fold (P,0.01) relative to the control vector-transduced DCs
(Fig. 1B and 1C). These results indicate that Nef expression in DCs
can promote DC-mediated HIV-1 transmission to CD4
+ T cells.
To examine the effect of HIV-1 Nef expression on DC-SIGN
and CD4 levels and DC maturation of the infected DCs, cell-
surface DC-SIGN, CD4 and the DC maturation marker CD86
were measured by flow cytometry. Nef expression in transduced
DCs significantly decreased CD4 expression by at least 43%
(Fig. 1D and 1E). The expression of DC-SIGN and CD86 was not
significantly modulated by Nef expression (Fig. 1D and 1E),
suggesting DC maturation was not affected by Nef expression in
transduced DCs. Thus, Nef expression in MDDCs can efficiently
enhance HIV-1 transmission and down-regulate CD4 expression.
Effects of Nef on HIV-1 infection and maturation of DCs
Our previous studies using replication-competent HIV-1
suggested that Nef facilitates DC-mediated viral transmission to
co-cultured CD4
+ T cells [40]. To better understand Nef-
dependent enhancement of HIV transmission by DCs, replica-
tion-competent HIV-1 expressing mutated Nef proteins were
compared with WT HIV-1 for their effects on HIV-1 infection
and maturation of DCs during a time-course up to 7 days post-
infection (dpi). Mutation of the Nef myristoylation motif (glycine to
arginine, G2A) or a conserved dileucine motif [L164L/AA (LL/
AA)] confers distinct defects on Nef function [41]. The G2A
mutant blocks Nef localization to the plasma membrane and the
LL/AA mutant disrupts Nef interactions with the clathrin
endocytosis machinery [30,41]. R5-tropic HIV-1NLAD8 and
derived Nef-inactivated virus were used because DCs are more
susceptible to R5 HIV-1 than to X4 HIV-1 infection [40,42].
The Nef expression of these viruses was confirmed by
immunoblotting (Fig. 2A). HIV-1 infection of DCs was compa-
rable between WT HIV-1 and the Nef-mutated viruses when p24
production was measured by enzyme-linked immunosorbent assay
(ELISA) (Fig. 2B). Compared with the mock-infected DCs, HIV-1
infected DCs showed decreased DC-SIGN surface levels over the
Figure 1. HIV-1 Nef enhances DC-mediated HIV-1 transmission to Hut/CCR5 T cells and modulates CD4 expression of DCs. Immature
DCs were generated from purified monocytes by treatment with GM-CSF and IL-4 for 5 days. Immature DCs were transduced with a Nef-expressing
lentiviral vector (Nef+) or a negative control vector (Nef2). (A) Nef expression in vector-transduced DCs was detected at five days post-transduction
by immunoblotting. HIV-1 p24 was used a positive control. (B and C) Nef expression in DCs promotes HIV-1 transmission. DC-mediated transfer of
single-cycle, Nef-defective, R5-tropic luciferase HIV-1 to CD4
+ Hut/CCR5 cells was measured at 2 days post-infection (dpi). The data show the mean 6
SD of triplicate samples of cells from two different donors. (A–C) One representative experiment out of four is shown. cps, counts per second. (D and
E) Transduced DCs were analyzed by flow cytometry for the positive percentage (D) and the mean intensity (E) of DC-SIGN, CD4 and CD86 expression
at 5 days post-transduction. The data show the mean 6 SD of three independent experiments. (B–E) *, Significant differences compared with the Nef-
negative controls (P,0.05).
doi:10.1371/journal.pone.0034521.g001
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maintained higher levels of DC-SIGN relative to DCs infected
with Nef-mutated viruses [Fig. 2C (P,0.05) and 2F]. Consistent
with our previous results [9], WT HIV-1 infection efficiently
decreased (P,0.05) surface CD4 expression in DCs relative to
DCs infected with Nef-mutated viruses at 5 dpi (Fig. 2D). Surface
CD4 levels of HIV-1 infected DCs were significantly decreased
(P,0.01) compared with mock-infected DCs and no significant
difference (P.0.05) between WT HIV-1 and Nef-mutated viruses
was observed at 7 dpi (Fig. 2D and 2G), perhaps because WT
HIV-1 and Nef-mutated viruses encode functional Vpu, which can
also efficiently down-regulate CD4 expression [43]. Surface CD86
expression in HIV-1 infected DCs increased at 5 and 7 dpi
compared with that of mock-infected DCs (Fig. 2E and 2H),
suggesting that HIV-1 infection induced DC maturation. The
CD86 levels of DCs infected with DNef HIV-1 were similar to or
slightly higher than those infected with WT and other Nef-
mutated viruses (Fig. 2E and 2H). Similar results were obtained
when DCs from two additional donors were examined. Together,
our results suggest that replication-competent HIV-1 infection of
DCs can down-regulate DC-SIGN and CD4 expression and
facilitate DC maturation in a largely Nef-independent manner.
Nef enhances HIV-1 infection of activated peripheral
blood lymphocytes (PBLs) and facilitates DC-mediated
HIV-1 transmission to activated autologous PBLs
To examine the effects of HIV-1 Nef expression on viral
replication and transmission in a physiologically relevant system,
HIV-1 infection of activated PBLs and DC-mediated HIV-1
transmission to autologous PBLs was compared using the WT
HIV-1 and Nef-mutated viruses. Compared with WT HIV-1, the
replication of DNef and Nef (LL/AA) HIV-1 was 4- to 5-fold lower
in activated PBLs, while the replication of Nef (G2A) mutant was
1.4-fold lower at 5 and 7 dpi (Fig. 3A). All three Nef-mutated
viruses showed impaired DC-mediated HIV-1 transmission to
activated PBLs, which was 2- to 4-fold lower (P,0.05) relative to
WT HIV-1 infection (Fig. 3B). At 3 dpi, although comparable
HIV-1 replication of WT HIV-1 and Nef-mutated viruses was
observed in activated PBLs (Fig. 3A), WT HIV-1 infected DCs
enhanced viral spread 3-fold more efficiently relative to Nef-
mutated viruses in DC-PBL cocultures (Fig. 3B). These results
suggest that Nef is important for efficient HIV-1 replication in
activated PBLs and DC-mediated HIV-1 transmission to activated
PBLs.
HIV-1 Nef activates primary resting CD4
+ T cells, resulting
in increased viral infection and T-cell proliferation
In the early stages of HIV-1 infection, the majority of CD4
+ T
cells are naı ¨ve and resting, and can be latently infected by HIV-1
[44,45]. Previous studies have indicated that wild-type Nef plays
an important role in HIV-1 infection and activation of CD4
+ T
cells [46,47]. To better understand the role of Nef in HIV-1
infection of resting CD4
+ T cells, we investigated the effect of WT
HIV-1 and Nef-mutated viruses on the activation of resting CD4
+
T cells and viral replication using cells from three different donors.
The expression levels of CD69, an early marker of CD4
+ T cell
activation [48], in WT HIV-1 infected cells were increased
compared to mock-infected control cells at 3 dpi (Fig. 4A),
indicating that HIV-1 infection activates resting CD4
+ T cells. By
contrast, all Nef-mutated viruses showed reduced or baseline levels
of CD69 expression compared to WT HIV-1-infected cells
(Fig. 4A), suggesting that functional Nef protein is required for
the activation of resting CD4
+ T cells. This trend correlated with
the levels of p24 in the supernatants, with the WT infected cells
showing increased p24 production over the Nef-mutated viruses at
3 dpi (Fig. 4B).
CD69 is a transient phenotypic marker of CD4
+ T cell
activation [49]. To functionally assess the effect of Nef expression
on resting CD4
+ T cell activation, we performed a flow cytometry
based T-cell proliferation assay using carboxyfluorescein diacetate
succinimidyl ester (CFSE) labeling and also measured p24
production over a period of 7 days of infection. We assessed p24
production by HIV-1-infected resting CD4
+ T cells from two
healthy donors. The p24 levels in the supernatants of WT HIV-1-
infected resting CD4
+ T cells were 6-fold higher (5 and 7 dpi,
P,0.02) than those of Nef-mutated HIV-1 infected T cells
(Fig. 5A). A similar trend was observed when the average results of
two donors were combined (Fig. 5B), suggesting that HIV-1
replication in resting CD4
+ T cells occurs in a Nef-dependent
manner. Furthermore, the reverse transcriptase inhibitor azido-
thymidine was able to completely block p24 production in the
supernatants, confirming productive HIV-1 replication in resting
CD4
+ cells (data not shown).
We then investigated whether the effect of Nef on HIV-1
infection of resting CD4
+ T cells correlated with Nef-dependent T-
cell proliferation. To evaluate the overall effect of Nef expression
on proliferation in resting CD4
+ T cells, data derived from three
different donors’ cells were combined (Fig. 5C). Whilst there was
large donor-to-donor variability, WT HIV-1 infected CD4
+ T cells
showed consistently higher T-cell proliferation at 5 dpi than mock-
infected and Nef-mutated HIV-1 infected cells (Fig. 5C). However,
there was no statistically significant difference in T-cell pro-
liferation among WT HIV-1 and Nef-mutated HIV-1 infected
CD4
+ T cells (Fig. 5C).
An increase in proliferation over time is consistent with active T
cell proliferation and survival of each subsequent generation,
whilst decreases in T cell proliferation are likely due to activation
induced CD4
+ T cell apoptosis or HIV-1-induced T cell death.
These results suggest that Nef facilitates resting CD4
+ T cell
activation and proliferation, thus providing an environment to
facilitate HIV-1 replication. It is also important to consider that
the resting CD4
+ T cells used in all of these experiments (Fig. 4, 5,
6) were in culture for 8 days in the presence of IL-2 (see
experiment procedures indicated in Fig. 6A); therefore, it is
possible that there is a degree of background activation in the
resting CD4
+ T cells. The decreases in the percentage of T cells
divided over time (Fig. 5C mock infected controls) were likely due
to activation-induced T cell death. Together, these results indicate
that Nef enhances the activation and proliferation of HIV-1-
infected resting CD4
+ T cells and viral replication in these cells.
HIV-1-infected DCs cannot significantly increase resting
CD4
+ T cell proliferation in DC-T cell co-cultures
To understand the potential role of Nef in the co-cultures of
HIV-1-infected DCs and CD4
+ T cells, we next investigated the
effect of Nef expression in DCs on the activation of co-cultured
resting CD4
+ T cells and on HIV-1 production. MDDCs were
infected with HIV-1 and the Nef-mutated viruses for 3 days to
allow productive infection to occur. At this point, autologous
resting CD4
+ T cells that had been cultured in media containing
interleukin-2 for the duration of the DC generation were added to
HIV-1-infected DCs at a cell number ratio of 1:1. Co-cultured
cells and the culture supernatants were collected and analyzed 3,
5, and 7 days later (Fig. 6A).
WT HIV-1 appeared to replicate more efficiently than all of the
Nef-mutated viruses at 3 and 5 days of co-culture, as assessed by
p24 production in the supernatants (Fig. 6B). For instance,
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a 6.6-fold and a 2.4-fold increase in p24 production over the Nef
(LL/AA) mutant at 3 and 5 days of co-cultures, respectively
(Fig. 6B), which were reproducible across three different donors.
Moreover, azidothymidine was able to completely block p24
production in the supernatants, confirming productive HIV-1
replication in co-cultures (data not shown).
To assess the role of CD4
+ T cell activation and proliferation in
the enhancement of HIV-1 production, CD69 staining and T-cell
proliferation assays were performed. To differentiate the T cells
from the DCs in the co-cultures, cells were additionally stained for
CD3, a general marker for T cells. At 3 days of co-culture, there
was a 2- to 3-fold increase of CD69 expression by CD3
+ T cells in
co-culture with HIV-1-infected DCs infected over the mock-
infected controls (Fig. 6C), while there were no significant
differences between WT HIV-1 and Nef-mutated viruses infected
cells (Fig. 6C). These data were also reproducible across three
different donors (not shown). When the T-cell proliferation data
from DC-T-cell co-cultures of five different donors were
combined, there was no consistent trend for Nef-dependent
proliferation of CD4
+ T cells (Fig. 6D). There was no statistically
significant difference in T-cell proliferation among WT HIV-1 and
Nef-mutated viruses infected CD4
+ T cells (Fig. 6D). These results
suggest that Nef-mediated enhancement of HIV-1 replication in
DC-T-cell co-cultures is not directly attributable to CD4
+ T cell
activation and proliferation.
Figure 2. Effects of Nef on HIV-1 infection and maturation of DCs. (A) Nef expression of wild-type (WT) HIV-1NLAD8 and Nef-mutated viruses
(DNef, G2A, and LL/AA). HEK293T cells transfected with proviral DNA were subjected to immunoblotting at two days post-transfection. HIV-1 p24 was
used as a positive control for viral protein expression and actin was a loading control. (B) Comparable infection of DCs with HIV-1NLAD8 WT and Nef-
mutated viruses. Immature DCs were generated from purified monocytes by treatment with GM-CSF and IL-4 for 5 days. DCs were infected with HIV-1
for 16 h and cells were washed thoroughly and cultured for the indicated time course. Cell-free supernatants from the infected DCs were measured
for HIV-1 p24 by ELISA at the indicated times. Error bars represent the standard deviation of the mean of triplicate samples. HIV-1 infected DCs were
analyzed by flow cytometry for the positive percentage and the mean intensity of DC-SIGN (C and F), CD4 (D and G) and CD86 expression (E and H).
The data shown represents one of three independent experiments using cells from three different donors.
doi:10.1371/journal.pone.0034521.g002
HIV-1 Nef Enhances DC-Mediated Viral Transmission
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e34521Discussion
In addition to DC-mediated HIV-1 trans-infection, long-term
viral transfer to CD4
+ T cells by DCs depends on HIV-1
production from infected DCs [6,7,50,51]. Thus, we examined
Nef modulation of DC-mediated HIV-1 transmission through de
novo production of virus. WT and Nef-mutated HIV-1 replicated
with similar kinetics in immature MDDCs. Nef expressing HIV-1-
Figure 3. Nef enhances HIV-1 infection of activated PBLs and DC-mediated HIV-1 transmission to activated autologous PBLs. (A) Nef
enhances HIV-1 replication in activated PBLs. HIV p24 in the cell supernatants of DCs infected with WT HIV-1NLAD8 or Nef-mutated viruses was
measured by ELISA. (B) Nef promotes DC-mediated HIV-1 transmission to activated PBLs. Immature DCs were generated from purified monocytes by
treatment with GM-CSF and IL-4 for 5 days. DCs infected with WT HIV-1NLAD8 or Nef-mutated viruses were co-cultured with PHA-activated autologous
PBLs and HIV p24 in the cell supernatants was measured. (A and B) The data show the mean 6 SD of triplicate samples. The data shown represents
one of four independent experiments using cells from four different donors.
doi:10.1371/journal.pone.0034521.g003
Figure 4. HIV-1 Nef activates primary resting CD4
+ T cells, resulting in increased T-cell proliferation and viral infection. (A) HIV-1 Nef
increases the expression of the transient T-cell activation marker CD69 in resting CD4
+ T cells infected with replication-competent WT or Nef-mutated
HIV-1 at 3 dpi. Mock-infected cells were used as background controls for CD69 staining and flow cytometry. Resting CD4
+ T cells were isolated from
PBMCs using immunomagnetic particles and were cultured in the presence of IL-2 before and during HIV-1 infection. Resting CD4
+ T cells were
cultured for 8 days, infected with 5 ng p24 of HIV-1 or a media control for 2 hours, washed and then cultured for an additional 3 days. The data
shown represents three independent experiments using cells from three different donors. (B) WT Nef increases p24 production in the supernatants of
HIV-1-infected resting CD4
+ T cells at 3 dpi. Mock-infected cells were used as negative controls (undetectable p24). Data from three different donors
are shown, which are matched to those in (A). Data displayed are the mean 6 SEM of duplicate samples for each infection except the results of donor
1, which show the p24 values from a single sample.
doi:10.1371/journal.pone.0034521.g004
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+ T
cells. Nef modulation of DC-SIGN and CD4 expression was
observed, though levels of DC-SIGN upregulation were limited in
lentiviral vector transduced DCs. Our time-course analysis of DCs
infected with replication-competent WT HIV-1 and Nef-mutated
viruses suggest that HIV-1 infection of DCs can down-regulate
DC-SIGN and CD4 expression in a largely Nef-independent
manner. By contrast, a previous study using immunofluorescence
microscopy showed that DC-SIGN surface levels are upregulated
in HIV-1-infected DCs at 4 dpi in a Nef-dependent manner,
which increases clustering of DCs with T lymphocytes and HIV-1
transmission [34]. Although different experimental approaches
might result in the discrepancy of the results, Nef-mediated DC-
SIGN upregulation may not fully explain DC-enhanced HIV-1
transmission to CD4
+ T cells. Previous studies indicated that DC-
SIGN only partially accounts for or plays very little role in DC-
mediated HIV-1 transmission [12,20,52]. Of note, differential
modulation of CD86 and DC-SIGN expression in DCs was
observed between lentiviral transduction and WT HIV-1 infection
(Fig. 1 and 2). The data in Fig. 1 represent a situation in which Nef
was expressed in trans, in the absence of other HIV-1 accessory
proteins. The results in Fig. 2 provide a model for what could
occur during WT HIV-1 infection, with all HIV-1 accessory genes
intact.
HIV-1 transmission efficiency can be enhanced by maturation
of DCs [22,53]. To exclude the possibility that Nef-promoted
HIV-1 transmission results from Nef-induced DC maturation, the
maturation marker CD86 was compared between WT and DNef
HIV-1-infected DCs, and no Nef-induced upregulation of the
maturation marker was observed. Similarly, adenovirus vector-
expressed HIV-1 Nef in immature DCs triggers cytokine and
chemokine production, and Nef-expressing DCs stimulate CD4
+
T cell activation; but without up-regulation of DC maturation
markers [36]. Thus, Nef may facilitate DC-mediated HIV-1
transmission by promoting DC-T cell interactions.
Nef-mediated suppression of T cell activation is a critical feature
of non-pathogenic primate lentiviruses and HIV-2, whereas HIV-
1 Nef induces T cell activation and contributes to viral
pathogenicity [54]. In addition to the modulation of CD4 and
DC-SIGN expression, HIV-1 Nef also down-regulates cell surface
expression of MHC class I, CCR5 and CD28 [55,56,57], but
upregulates surface expression of the invariant chain of MHC class
II, TNF and the related LIGHT cytokines [58,59]. Although there
is no evidence that these modulations, other than CD4 and DC-
SIGN expression, can affect DC-mediated HIV-1 transmission,
Nef-mediated modulation of T cell function also contributes to
viral transmission in vivo.
HIV-1 Nef plays a multifaceted role in viral infection and
pathogenesis [29]. It has been previously shown that deletion of
Nef and specific mutations in important Nef motifs, including the
Nef (G2A) and Nef (LL/AA) mutants utilized in these experiments,
causes attenuated HIV-1 replication in activated CD4
+ T cells
Figure 5. Nef promotion of HIV-1 replication in primary resting CD4
+ T cells is associated with T cell proliferation. Resting CD4
+ T cells
were isolated from PBMCs using immunomagnetic particles and were cultured in the presence of IL-2 before and during HIV-1 infection. (A) Resting
CD4
+ T cells were cultured for 8 days and then infected with 5 ng p24 of replication-competent WT or Nef-mutated HIV-1. HIV-1 p24 production in
the supernatants was measured at the times indicated. Representative data from one donor are shown. (B) Resting CD4
+ T cells were cultured for 8
days and then infected with 5 ng p24 of WT HIV-1 or Nef-mutated viruses. HIV-1 p24 production in the supernatant was measured at the times
indicated. Mean values of two independent experiments on different donors are shown. (C) CFSE-labeled resting CD4
+ T cells (cultured for 8 days in
the presence of IL-2) were mock infected or infected with 5 ng p24 of WT or Nef-mutated HIV-1. CD4
+ T cell proliferation was measured by flow
cytometry at the indicated times. Data represent three independent experiments using cells from three different donors. Each symbol in the plots
represents a single experiment result and the horizontal bars in the plots indicate the mean values of three independent experiments. There is no
statistically significant difference in T-cell proliferation among WT and Nef-mutated HIV-1 infected CD4
+ T cells.
doi:10.1371/journal.pone.0034521.g005
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1 replication in primary CD4
+ T cells by enhancing virion-
associated gp120 levels of infected cells [61]. Moreover, Nef
stimulates HIV-1 proviral DNA synthesis [62], and enhances
HIV-1 infectivity resulting from inter-virion fusion [63]. It has
been shown that Nef can be transferred from HIV-1-infected
CD4
+ cells to bystander cells upon cell-to-cell contact and
contribute to the detrimental effect on bystander cells in viral
infection [64]. Here we demonstrate that during direct infection of
resting CD4
+ T cells, HIV-1 is capable of causing activation and
proliferation of resting CD4
+ T cells in vitro, while deletion of Nef
and mutations within Nef can reduce this effect. Enhanced
infection of CD4
+ T cells by the WT HIV-1 was observed by p24
quantification, indicating that HIV-1 is capable of facilitating its
own replication by causing resting CD4
+ T cell activation and
proliferation, and that functional Nef protein plays a significant
role in this activation process.
In DC-T-cell co-culture experiments, Nef expression by infected
DCs did not appear to significantly enhance CD69 expression or
proliferation of co-cultured CD4
+ T cells above background
activation caused by the co-culture itself. Nevertheless, Nef-
mutated HIV-1 do not replicate as efficiently in these co-cultures
as WT HIV-1 and are transmitted less efficiently than WT HIV-1.
DCs are refractory to productive HIV-1 infection [3], which may
Figure 6. HIV-1-infected DCs cannot significantly increase resting CD4
+ T cell proliferation in DC-T cell co-cultures. (A) Schematic
representation of the experiment procedures. Primary MDDCs and autologous resting CD4
+ T cells were used. (B) DCs infected with replication-
competent WT or Nef-mutated HIV-1 were co-cultured with uninfected resting CD4
+ T cells and HIV-1 p24 production in the supernatants was
measured at the indicated times of co-cultures. Immature DCs were generated from purified monocytes by treatment with GM-CSF and IL-4 for 5
days. Resting CD4
+ T cells were isolated from PBMCs using immunomagnetic particles and were cultured in the presence of IL-2 for 8 days. (C) Co-
culture with HIV-1-infected DCs increases the surface expression of the transient T-cell activation marker CD69 on resting CD4
+ T cells. CD69
expression was assessed at 3 days of co-cultures by flow cytometry. Mock-infected cells were used as background controls. These data are donor
matched to Figure 6B. (D) CD4
+ T cell proliferation in the co-cultures of HIV-1 infected DCs. DCs were mock infected or infected with WT or Nef-
mutated HIV-1 for 3 days prior to co-culture with CFSE-labeled, uninfected resting CD4
+ T cells. T cell proliferation was measured by flow cytometry at
the indicated times of co-cultures. Data represent five independent experiments using cells from five different donors. Each symbol in the plots
represents a single experiment result and the horizontal bars in the plots indicate the mean values of five independent experiments.
doi:10.1371/journal.pone.0034521.g006
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+ T cells in
cocultures. HIV-1 can efficiently induce DC maturation and
activation of cocultured CD4
+ T cells when the HIV-1 restriction
in DCs is circumvented by SIV Vpx [65]. Recent studies have
identified SAMHD1 as the DC- and myeloid-cell-specific HIV-1
restriction factor, which can be antagonized by Vpx proteins from
sooty mangabey SIV or HIV-2 [66,67]. Further investigation of
the mechanisms underlying SAMHD1-mediated HIV-1 restriction
in DCs and myeloid cells can aid in the understanding of viral
pathogenesis [68].
In summary, we demonstrated that HIV-1 Nef enhances DC-
mediated HIV-1 transmission to activated CD4
+ T cells. HIV-1
Nef contributes to the activation and proliferation of infected
resting CD4
+ T cells. By contrast, Nef expression in infected DCs
does not significantly affect DC-mediated CD4
+ T cell activation
or proliferation. These results provide new information in
understanding the function of Nef as a viral pathogenic factor.
Materials and Methods
Plasmids
HIV-1 proviral vector pNL-Luc-E
2R
2 contains a firefly
luciferase reporter gene [69]. The R5-tropic HIV-1JRFL envelope
(Env) expression plasmid pJRFL has been previously described [9].
HIV-1-based expression vectors pH 131 and pH 132 were kind
gifts from Dr. Derya Unutmaz (New York University). These
vectors with vif, vpr, vpu, and env deletions were derived from the
HIV-1-eGFP construct [39]. The control vector, pH 131, has the
encephalomyocarditis virus internal ribosomal entry site (IRES)
and mouse heat stable antigen (HSA) in place of nef, pH 132 has
a nef-IRES-HSA cassette and expresses full-length WT HIV-1
Nef. WT HIV-1 proviral vector pNLAD8 (R5-tropic) was a kind
gift from Eric Freed [70] (National Cancer Institute-Frederick).
HIV-1 nef-inactivated proviral vector pNLAD8DNef was a kind
gift from Olivier Schwartz (Pasteur Institute). Proviral DNA
expressing Nef (G2A) and Nef (LL/AA) mutants in the pNLAD8
backbone were generated as described [32] and confirmed by
DNA sequencing.
Cell culture
Human PBMCs were isolated from the buffy coat of healthy
donors (American Red Cross Blood Service, Columbus, Ohio) as
previously described [9]. Human primary CD14
+ monocytes and
CD4
+ T cells were isolated from PBMCs using gradient
centrifugation and immunomagnetic particles as described [9].
Immature DCs were generated from purified monocytes by
treatment with granulocyte-macrophage colony-stimulating factor
(GM-CSF) and interleukin 4 (IL-4) (50 ng/ml, R&D Systems) for 5
days as described [71]. Primary resting CD4
+ T cells were cultured
in the presence of 20 IU/ml of recombinant interleukin-2 (IL-2)
(the NIH AIDS Research and Reference Reagent Program) and
activated by phytohemagglutinin (PHA, 5 mg/ml) for 2 days as
previously described [9]. PHA-activated PBLs were generated as
previously described [9]. DCs and CD4
+ T cells were more than
98% pure by flow cytometry analysis of surface markers as
described [5]. Human embryonic kidney cell line HEK293T,
human T cell line Hut/CCR5, and HIV-1 indicator cell line
GHOST/X4/R5 (kind gifts from Dr. Vineet KewalRamani,
National Cancer Institute, Frederick, Maryland, USA) have been
previously described [20,71,72].
HIV-1 stocks
The single-cycle infectious HIV-1 stocks were generated by
calcium phosphate cotransfection of HEK293T cells with the
pNL-Luc-E
2R
2 and an expression plasmid for HIV-1JRFL Env as
described [20]. Replication-competent WT and Nef-mutated
HIV-1 stocks were generated separately by transfection of
HEK293T cells [20] with proviral vectors pNLAD8, pNLAD8D-
Nef, pNLAD8Nef (LL/AA), or pNLAD8Nef (G2A) as described
[9]. All virus stocks were harvested 2 days post-transfection. The
infectious units of virus stocks were evaluated by limiting dilution
on GHOST/X4/R5 cells [20] as described [20]. HIV-1 p24
concentrations of viral stocks were measured by ELISA (SAIC-
Frederick) as described [5].
Cell transduction with the H131 and H132 vectors
Nef-expressing vector H132 and the control vector H131 were
generated by co-transfection of HEK293T cells with pH 132 or
pH 131 and the VSV-G expressing construct pVSV-G as
described [20]. Immature DCs (2610
6) were incubated separately
with VSV-G-pesudotyped H131 and H132 vectors for 2 hours in
the presence of DEAE-dextran (10 mg/ml) as described [9].
Transduced DCs were washed and cultured for 5 days before
immunoblotting and flow cytometry analyses.
Immunoblotting
The H131 and H132 vector-transduced DCs and HEK293T
cells that were transfected separately with pH 131, pH 132, or
HIV-1 proviral DNA were lysed with 1% Triton X-100
supplemented with the presence of the protease inhibitor cocktail
(Sigma-Aldrich). Cell lysates were subjected to 15% SDS-PAGE
and immunoblotting as described [8]. Anti-Nef (1:500) and human
HIV-1 immunoglobulin (1:3,000, both from the NIH Research
and Reference AIDS Reagent Program) were used as primary
antibodies. Horseradish peroxidase-conjugated anti-mouse IgG
(1:5,000, Promega) or anti-human IgG (1:25,000, Promega) were
used as secondary antibodies respectively. Restore Western blot
stripping buffer (Pierce) was used to strip antibodies from probed
membranes. Super-Signal chemiluminescence substrates (Pierce)
were used to detect secondary antibodies.
Flow cytometry
Cells (1610
5) were stained with specific monoclonal antibodies
or isotype-matched IgG controls (2 mg/ml) as previously described
[9]. Phycoerythrin (PE)- or fluorescein isothiocyanate (FITC)-
conjugated mouse anti-human monoclonal antibodies against the
following molecules were used in immunostaining: CD4 (clone
S3.5; Caltag Laboratories), DC-specific intercellular adhesion
molecule-3-grabbing non-integrin (DC-SIGN, clone number
120507; R&D Systems), CD86 (clone number BU63; Invitrogen).
Negative controls were antibodies matched for isotype and
fluorescent conjugation: mouse IgG2a (PE-conjugate; BD Bios-
ciences), mouse IgG2 (FITC-conjugate; BD Biosciences) or mouse
IgG1 (FITC-conjugate; Invitrogen) respectively. Stained cells were
analyzed using a FACSCalibur or a Guava EasyCyte flow
cytometer (Millipore) and data was analyzed using the CellQuest
program (Becton Dickinson) or FlowJo software (Tree Star) as
previously described [12].
HIV-1 infection and transmission assays
HIV-1 transmission and infection assays using luciferase viruses
were performed as described previously [20]. Cell lysates were
obtained 2 days after infection and analyzed for luciferase activity
with a commercially available kit (Promega). For DC infection and
transmission assays using replication-competent HIV-1, DCs
(2.5610
5) were incubated separately with WT and Nef-mutated
HIV-1 (50 ng p24) for 16 h. Cells were then washed thoroughly
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from the HIV-1-infected DCs were harvested for Gag p24
quantification by ELISA at the indicated times post-infection.
Resting CD4
+ T cells (3610
5) were infected with 5 ng p24 of HIV-
1NLAD8 WT or Nef-mutated viruses, or a media control, for
2 hours at 37uC, washed once in PBS and then cultured for 3, 5 or
7 days. CD4
+ T cells were resuspended at 5610
5 cells/ml and
added directly to the infected DCs at a ratio of 1:1. HIV-1 p24
levels in the supernatants of infected cells were measured by
ELISA at the indicated times.
Assessment of CD69 expression as a marker of CD4
+ T
cell activation
Cells were harvested 3 dpi and fixed in 2% paraformaldehyde
for 1 hour at 4uC. The fixed cells were stained with a PE-
conjugated antibody to CD69 (clone number FN51; BD
Biosciences) and a FITC-conjugated antibody to CD3 (clone
number HIT3a; BD Biosciences). Cells were assessed by flow
cytometry using a Guava EasyCyte Mini and the percentage cells
CD69 positive was measured. In DC-T cell co-cultures, cells were
first analyzed for CD3 expression, then the highly CD3-positive T
cells were gated and analyzed for CD69 expression.
CD4
+ T cell proliferation assay
Purified resting CD4
+ T cells were labeled with CFSE according
to the manufacturer’s instructions (Molecular Probes), infected and
cultured or co-cultured with DCs as described above. At indicated
time points, cells were harvested from culture and fixed in 2%
paraformaldehyde for 1 hour at 4uC. Cells were assessed by flow
cytometry using a Guava EasyCyte mini and proliferation was
quantified using the proliferation analysis platform of the FLowJo
flow cytometry software (Tree Star).
Statistical analysis
Data were analyzed using a two-way ANOVA test and
Bonferroni post-test or non-parametric ANOVA. Statistical
significance was defined as P,0.05.
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